Head-to-Head Comparison of GHRP-2 and Hexarelin for Growth Hormone Release in Humans

GHRP-2 and hexarelin both potently stimulate GH release in humans with slight effects on prolactin, ACTH, and cortisol — their first direct head-to-head comparison.

Arvat, E et al.·Peptides·1997·Strong EvidenceRCT
RPEP-00397RCTStrong Evidence1997RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
RCT
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

GHRP-2 and hexarelin both showed potent GH-releasing activity with slight stimulatory effects on prolactin, ACTH, and cortisol; their GH-releasing activities were directly compared for the first time.

Key Numbers

How They Did This

Randomized clinical trial comparing GHRP-2, hexarelin, GHRH, TRH, and CRH administration in healthy men, measuring GH, prolactin, ACTH, and cortisol responses.

Why This Research Matters

This head-to-head comparison helps clinicians and researchers choose between the two most popular GHRPs and understand their hormonal side effect profiles.

The Bigger Picture

This comparative study helped establish the relative positioning of different GHRPs and inform clinical decision-making about which secretagogue to use.

What This Study Doesn't Tell Us

Acute single-dose study in healthy men only. No women included. Long-term effects and functional outcomes not assessed.

Questions This Raises

  • ?Which GHRP has the best GH-specificity with fewest off-target hormonal effects?
  • ?Do the prolactin and cortisol effects of GHRPs diminish with chronic use?

Trust & Context

Key Stat:
First head-to-head comparison GHRP-2 and hexarelin were directly compared for the first time in humans for GH and multiple other hormone effects
Evidence Grade:
Strong evidence from a randomized clinical trial with multiple comparators. Comprehensive hormonal profiling provides clinically useful data.
Study Age:
Published in 1997, this remains a key reference for comparing GHRP-2 and hexarelin hormonal profiles.
Original Title:
Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
Published In:
Peptides, 18(6), 885-91 (1997)
Database ID:
RPEP-00397

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Which is better — GHRP-2 or hexarelin?

Both are potent GH releasers. This study provided their first direct comparison. GHRP-2 tends to be slightly more potent based on other studies, but both have similar hormonal profiles with slight prolactin and cortisol stimulation alongside GH release.

Why do GHRPs also affect prolactin and cortisol?

GHRP receptors are not exclusively on GH-producing cells. They're also present on cells that produce prolactin and ACTH (which drives cortisol). The effects on these hormones are typically mild compared to the GH response, but they're important to monitor.

Read More on RethinkPeptides

Cite This Study

RPEP-00397·https://rethinkpeptides.com/research/RPEP-00397

APA

Arvat, E; di Vito, L; Maccagno, B; Broglio, F; Boghen, M F; Deghenghi, R; Camanni, F; Ghigo, E. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.. Peptides, 18(6), 885-91.

MLA

Arvat, E, et al. "Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.." Peptides, 1997.

RethinkPeptides

RethinkPeptides Research Database. "Effects of GHRP-2 and hexarelin, two synthetic GH-releasing ..." RPEP-00397. Retrieved from https://rethinkpeptides.com/research/arvat-1997-effects-of-ghrp2-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.